According to this market research, sales revenue of Lenalidomide in the Chinese market has an increasing trend from 2016 to 2020. Especially after Lenalidomide was included in the national medical insurance catalog in the second half of 2017, the annual growth rate in 2018 reached 547.4%. In 2020, the annual growth rate slowed down due to the COVID-19 epidemic, which affected the overall hospital operation. The sales value of Lenalidomide was CNY297.4 million in 2020 and the CAGR of Lenalidomide from 2016 to 2020 is 98.7% in China.
The analyst analyzes that as the epidemic situation has been improved and the hospitals resume their operation, sales of Lenalidomide will have a recovery growth from 2021 to 2025. Besides, sales will also increase due to price reduction and market expansion. In recent years, with the emergence of generic drugs, the price of Lenalidomide has kept decreasing, which increases the usage rate of Lenalidomide among Chinese patients. At the same time, Lenalidomide applied for its third indication in China in March 2021. As the number of approved indications increases in China, sales will continue to grow.
Topics Covered:
- The impact of COVID-19 on China's Lenalidomide market
- Sales value and volume of China's Lenalidomide 2016-2020
- Competitive landscape of China's Lenalidomide market
- Prices of Lenalidomide in China
- Prices of Lenalidomide in China by regions and manufacturers
- Analysis of factors affecting the development of China's Lenalidomide market
- Prospect of China's Lenalidomide market from 2021 to 2025
Table of Contents
Samples
LOADING...
Companies Mentioned
- Beijing SL Pharmaceutical Co., Ltd.
- Celgene Europe BV
- Celgene Europe Ltd.
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Qilu Pharmaceutical Co., Ltd.
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
Table Information
Report Attribute | Details |
---|---|
Published | April 2021 |
Forecast Period | 2016 - 2025 |
Estimated Market Value ( CNY | CNY 19.2 Million |
Forecasted Market Value ( CNY | CNY 2258 Million |
Compound Annual Growth Rate | 70.0% |
Regions Covered | China |
No. of Companies Mentioned | 5 |